1.
Kumari R, Chaugule A,
Goyal PK. Karyoanomalic
frequency during radiation therapy. J Cancer Res Ther.
2005;1:187-90.
http://dx.doi.org/10.4103/0973-1482.19604
|
|
2.
Umiker W, Lampe I, Rapp R, Latourette H, Boblitt D. Irradiation effects on malignant cells in smears from oral cancers; a preliminary report. Cancer.
1959;12:614-9.
http://dx.doi.org/10.1002/1097-0142(195905/06)12:3<614::AID-CNCR2820120322>3.0.CO;2-X
|
|
|
3.
Trotti A. Toxicity in
head and neck cancer:
a review of trends
and issues. Int J Radiat Oncol Biol Phys. 2000;47:1-12.
http://dx.doi.org/10.1016/S0360-3016(99)00558-1
|
|
|
4.
Parulekar W, Mackenzie R, Bjarnason
G, Jordan RC. Scoring
oral mucositis. Oral Oncol.
1998;34:63-71.
http://dx.doi.org/10.1016/S1368-8375(97)00065-1
|
|
|
5.
Spijkervet FK, van Saene
HK, Panders AK, Vermey
A, Mehta DM. Scoring irradiation mucositis in
head and neck cancer patients. J Oral Pathol Med. 1989;18:167-71.
http://dx.doi.org/10.1111/j.1600-0714.1989.tb00756.x
|
|
|
6.
Sonis ST. Mucositis
as a biological process:
a new hypothesis for thedevelopment of chemotherapy-induced
stomatotoxicity. Oral Oncol.
1998;34:39-43.
http://dx.doi.org/10.1016/S1368-8375(97)00053-5
|
|
|
7.
de Mendona RM, de Arajo
M, Levy CE, Morari J, Silva RA, Yunes JA, et al. Prospective
evaluation of HSV, Candida
species and oral bacteria on
the severity of oral mucositis in pediatric acute lymphoblastic leukemia. Support Care Cancer.
2012;20:1101-7.
http://dx.doi.org/10.1007/s00520-011-1190-0
|
|
|
8.
Bensadoun RJ, Magn
N, Marcy PY, Demard
F. Chemotherapy- and radiotherapy-induced
mucositis in head and neck
cancer patients: new trends in pathophysiology, prevention and treatment. Eur Arch Otorhinolaryngol. 2001;258:481-7.
http://dx.doi.org/10.1007/s004050100368
|
|
|
9.
Phillips TL, Fu KK. Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer. 1976;37:1186-200.
http://dx.doi.org/10.1002/1097-0142(197602)37:2+<1186::AID-CNCR2820370830>3.0.CO;2-V
|
|
|
10.
Wymenga AN, van der Graaf
WT, Spijkervet FL, Timens
W, Timmer-Bosscha H, Sluiter
WJ, et al. A new in vitro assay for quantitation of chemotherapy-induced mucositis.
Br J Cancer. 1997;76:1062-6.
http://dx.doi.org/10.1038/bjc.1997.508
|
|
|
11.
Sonis ST. Management of Oral Mucositis. Cancer.
2004;100:1995-2025.
http://dx.doi.org/10.1002/cncr.20162
|
|
|
12.
Ahmed HG, Elemirri DA. Assessment
of oral cytological changes
associated with exposure to chemotherapy and/or radiotherapy. Cytojournal.
2009;6:8.
http://dx.doi.org/10.4103/1742-6413.51332
|
|
|
13.
Toth BB, Martin JW, Fleming TJ. Oral complications associated with cancer therapy. An M. D. Anderson Cancer Center experience. Journal of clinical periodontology. 1990:17:508-15.
http://dx.doi.org/10.1111/j.1365-2710.1992.tb01225.x
|
|
|
14.
Kstler WJ, Hejna M, Wenzel C, Zielinski CC.
Oral mucositis complicating
chemotherapy and/or radiotherapy: options for prevention and treatment. CA: a cancer journal for clinicians. 2001:51:290-315.
http://dx.doi.org/10.3322/canjclin.51.5.290
|
|
|
15.
Sonis ST, Eilers JP,
Epstein JB, LeVeque FG, Liggett
WH, Mulagha MT, et al. Validation
of a new scoring system
for the assessment of clinical
trial research of oral mucositis
induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 1999;85:2103-13.
http://dx.doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0
|
|
|
16.
Sonis ST, Woods PD, White BA. Oral complications of cancer therapies. Pretreatment
oral assessment. NCI Monogr.
1990:29-32.
|
|
|
17.
Harris DJ. Cancer treatment-induced
mucositis pain: strategies for assessment and management. Ther Clin Risk Manag. 2006;2:251-8.
http://dx.doi.org/10.2147/tcrm.2006.2.3.251
|
|
|
18.
Stokman MA, Spijkervet
FK, Wymenga AN, Burlage
FR, Timens W, Roodenburg
JL, et al. Quantification of oral mucositis due to radiotherapy by determining viability and maturation of
epithelial cells. J
Oral Pathol Med.
2002;31:153-7.
http://dx.doi.org/10.1034/j.1600-0714.2002.310305.x
|
|
|
19.
Scully C, Epstein J, Sonis
S. Oral mucositis: a challenging
complication of radiotherapy,
chemotherapy, and radiochemotherapy:
part 1, pathogenesis
and prophylaxis of mucositis.
Head & neck. 2003:25:1057-70.
http://dx.doi.org/10.1002/hed.10318
|
|
|
20.
Archibald D, Lockhart
PB, Sonis ST, Ervin
TJ, Fallon BG, Miller D, et al. Oral complications of multimodality
therapy for advanced squamous cell carcinoma of head and neck.
Oral Surg Oral Med
Oral Pathol. 1986;61:139-41.
http://dx.doi.org/10.1016/0030-4220(86)90174-X
|
|
|
21.
Rosenthal DI. Consequences
of mucositis-induced treatment
breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol.
2007:5:23-31.
|
|
|